Residency · Residency · Urology

Radical Prostatectomy: Open, Laparoscopic, and Robotic Approaches

Overview

Radical prostatectomy involves a surgical technique that emphasizes nerve-sparing principles, lymph node dissection templates, and perioperative outcomes. Different surgical approaches carry distinct complication profiles, which are important to consider when selecting the optimal method for each patient.

Indications

Radical prostatectomy is primarily indicated for clinically localized prostate cancer, classified as cT1 to cT3a, with curative intent. It is generally recommended for patients with a life expectancy of at least 10 years. This surgery can be performed across all risk categories, including low-risk patients who are not suitable candidates for active surveillance, as well as intermediate, high, and select very high-risk cases. Younger patients often prefer this approach due to its durable oncologic outcomes and the avoidance of radiation-related toxicity. Additionally, radical prostatectomy can be incorporated into multimodal treatment plans for locally advanced disease, such as cT3 to cT4 stages.

Surgical Approaches

Retropubic Radical Prostatectomy (Open RRP)

The open retropubic radical prostatectomy, historically the gold standard since Walsh described the technique in 1982, is performed through a midline or Pfannenstiel incision. Surgeons may use either an antegrade or retrograde dissection approach, benefiting from direct visualization and tactile feedback during the procedure. Although its frequency has declined with the advent of minimally invasive techniques, open RRP remains relevant, particularly in resource-limited settings.

Laparoscopic Radical Prostatectomy (LRP)

Laparoscopic radical prostatectomy can be performed via a transperitoneal or extraperitoneal approach. This technique is technically demanding and requires a steep learning curve, often necessitating over 200 cases to achieve proficiency. In many centers, laparoscopic prostatectomy has been largely replaced by the robotic approach due to its advantages.

Robot-Assisted Laparoscopic Prostatectomy (RALP)

Robot-assisted laparoscopic prostatectomy is currently the most common approach in the United States and Europe, accounting for over 85% of radical prostatectomies. The da Vinci robotic platform provides three-dimensional magnification, wristed instruments, and tremor filtering, enhancing surgical precision. The procedure is usually performed transperitoneally, although an extraperitoneal, Retzius-sparing variant is also available. RALP offers advantages such as reduced blood loss, shorter hospital stays, and faster convalescence. Surgeons typically require 150 to 250 cases to achieve proficiency.

Key Surgical Steps (RALP — Standard Transperitoneal)

Patient Positioning

Patients are positioned supine with a steep Trendelenburg tilt of 25 to 30 degrees. The arms are tucked, and shoulder braces or a bean bag are used to prevent sliding. Sequential compression devices are applied to the lower extremities to reduce the risk of venous thromboembolism.

Port Placement

Typically, six ports are placed in a fan configuration across the lower abdomen. These include a 12mm camera port, three 8mm robotic instrument arms, one 12mm assistant port, and one 5mm assistant port.

Surgical Steps (Antegrade Approach)

The procedure begins with mobilization of the bladder by dropping it and developing the space of Retzius. Bilateral incisions are made in the endopelvic fascia to expose the levator ani muscles and the prostatic apex. The dorsal venous complex (DVC) is controlled via suture ligation or stapling to minimize bleeding. The bladder neck is then transected carefully, preserving the ureteral orifices. Dissection of the seminal vesicles and vas deferens follows, typically through a posterior approach via the pouch of Douglas or an anterior approach; the vas deferens is isolated and divided, and the seminal vesicles are mobilized. Posterior dissection develops the plane between the prostate and rectum by incising Denonvilliers fascia. The lateral pedicles, which contain the prostatic blood supply, are controlled and divided, with nerve-sparing performed at this stage if indicated. Apical dissection involves dividing the DVC and urethra at the apex, ensuring negative surgical margins. The prostate specimen is retrieved in an entrapment bag and removed through an extended port site. Vesicourethral anastomosis is performed using running or interrupted sutures, typically 3-0 barbed suture, to achieve a watertight closure over a catheter. Pelvic lymph node dissection may be performed either before or after prostatectomy, depending on surgeon preference.

Nerve-Sparing Technique

Anatomy of Neurovascular Bundles (NVB)

The cavernous nerves responsible for erectile function travel posterolaterally to the prostate within the neurovascular bundle, which lies between the prostatic fascia and the levator fascia. These nerves originate from the pelvic plexus, receiving parasympathetic fibers from S2 to S4 and sympathetic fibers from T11 to L2. There are three planes of dissection relevant to nerve-sparing: intrafascial, interfascial, and extrafascial. The intrafascial plane is closest to the prostate and offers the best nerve preservation but carries the highest risk of positive surgical margins. The interfascial plane lies between the prostatic and levator fascia and represents the standard nerve-sparing approach. The extrafascial plane involves wide excision outside the levator fascia and does not preserve nerves.

Nerve-Sparing Decision-Making

Decisions regarding nerve-sparing are based on preoperative risk assessment, including cancer location, tumor volume, and MRI findings. Full bilateral nerve-sparing is appropriate for low-risk, organ-confined disease. Unilateral nerve-sparing may be considered when risk factors are present on only one side, such as positive biopsy cores or MRI lesions abutting the capsule. Non-nerve-sparing wide excision is reserved for high-risk features, palpable T3 disease, or concerns about extraprostatic extension. Intraoperative frozen section analysis of the neurovascular bundle margin can assist in guiding the extent of nerve preservation.

Retzius-Sparing (Bocciardi Technique)

The Retzius-sparing approach accesses the prostate entirely through the pouch of Douglas, avoiding entry into the space of Retzius. This technique preserves the puboprostatic ligaments, dorsal venous complex, and anterior supports, potentially allowing for earlier continence recovery. However, it is technically more demanding and may be associated with higher positive surgical margin rates. Long-term oncologic outcomes are comparable to the standard approach when performed by experienced surgeons.

Pelvic Lymph Node Dissection (PLND)

Standard Template

The standard lymph node dissection template includes the external iliac vein as the lateral border and the obturator fossa medial to the external iliac vein, removing obturator and external iliac nodes. However, this template misses approximately 50% of positive nodes.

Extended Template

The extended template adds dissection of the internal iliac, presacral, and common iliac nodes to the standard template. This approach detects two to three times more positive nodes. The National Comprehensive Cancer Network (NCCN) recommends extended PLND for patients with unfavorable intermediate and high-risk disease. While the staging benefit of extended PLND is clear, its therapeutic benefit remains debated.

When to Perform PLND

Pelvic lymph node dissection can be omitted in very low and low-risk disease where the risk of lymph node metastasis is less than 2%. Nomogram-based risk assessments, such as the Briganti or MSKCC nomograms, help guide this decision. Extended PLND is generally performed when the estimated risk of positive nodes exceeds 5%. To ensure adequate staging, a minimum lymph node count of 10 to 14 nodes is recommended.

Perioperative Considerations

Blood Loss and Transfusion

Robot-assisted laparoscopic prostatectomy typically results in a median estimated blood loss (EBL) of 100 to 300 mL, significantly less than the 500 to 1000 mL seen with open retropubic prostatectomy. Correspondingly, transfusion rates are lower with RALP, ranging from 1 to 3%, compared to 5 to 20% with open surgery.

Hospital Stay

Patients undergoing RALP usually stay in the hospital for one night, with some centers offering same-day discharge programs. In contrast, open surgery patients typically require 2 to 4 days of hospitalization.

Catheter Duration

Postoperatively, urinary catheters are generally maintained for 7 to 14 days. Some centers perform a cystogram before catheter removal, although many remove the catheter without imaging. Ensuring a watertight vesicourethral anastomosis is critical to minimize the risk of bladder neck contracture.

VTE Prophylaxis

Mechanical prophylaxis with sequential compression devices is used intraoperatively and postoperatively. Pharmacologic prophylaxis, such as enoxaparin, is considered for patients at high risk of venous thromboembolism. Early ambulation is encouraged to further reduce this risk.

Complications

Intraoperative

Rectal injury occurs in approximately 0.5 to 2% of cases and is managed with primary two-layer repair and omental interposition. Ureteral injury is rare (<1%) but requires prompt recognition and either reimplantation or stenting. Obturator nerve injury can occur during pelvic lymph node dissection and is minimized by nerve-sparing dissection techniques. Vascular injuries, such as iliac vein injury during PLND, are also possible.

Early Postoperative

Early postoperative complications include ileus in 2 to 5% of patients and urine leak from the anastomosis in 1 to 3%, which is usually managed with prolonged catheterization. Lymphocele formation occurs in 1 to 3% of patients after PLND and may require observation, aspiration, or creation of a peritoneal window. Deep vein thrombosis and pulmonary embolism occur in 1 to 2% of cases. Wound infections are more common with the open approach.

Late

Urinary incontinence affects 5 to 20% of patients at 12 months postoperatively, predominantly presenting as stress incontinence. Immediate continence, defined as no pad use at catheter removal, is seen in 30 to 50% of patients. Continence typically improves over 3 to 12 months, with some patients experiencing improvement up to 24 months. Risk factors for incontinence include older age, non-nerve-sparing surgery, prior transurethral resection of the prostate (TURP), and obesity. Erectile dysfunction occurs in 30 to 70% of patients depending on nerve-sparing status, baseline function, and age. Men under 60 with bilateral nerve-sparing and good baseline function have a 60 to 70% chance of potency recovery, which may take 12 to 24 months. Penile rehabilitation protocols are often advocated. Bladder neck contracture occurs in 1 to 5% of patients and is treated with dilation or incision. Inguinal hernia develops in 10 to 20% of patients after transperitoneal RALP, likely related to preperitoneal dissection.

Oncologic Outcomes

Positive Surgical Margins (PSM)

The overall positive surgical margin rate ranges from 10 to 25%, with rates of 5 to 15% in pT2 disease and 30 to 50% in pT3 disease. The most common sites for positive margins are the apex, posterolateral aspects, and bladder neck. While PSM increases the risk of biochemical recurrence, it does not always necessitate adjuvant treatment. Decisions regarding adjuvant versus salvage radiation therapy for PSM are addressed in radiation therapy guidelines.

Biochemical Recurrence

Biochemical recurrence is defined as a prostate-specific antigen (PSA) level of 0.2 ng/mL or higher, confirmed on repeat testing after radical prostatectomy. Ten-year biochemical recurrence-free survival rates range from 70 to 90% for organ-confined disease. High-risk features such as seminal vesicle invasion, positive lymph nodes, and positive surgical margins increase the risk of recurrence.

Cancer-Specific Survival

Fifteen-year cancer-specific survival rates are excellent, between 95 and 99% for organ-confined disease. Even among patients who experience biochemical recurrence, many have indolent disease with long prostate-specific antigen doubling times.

<image>A labeled surgical anatomy diagram showing the lateral view of the prostate, neurovascular bundles, and surrounding structures during radical prostatectomy. Key structures labeled include: prostatic fascia, levator fascia, neurovascular bundle (posterolateral), Denonvilliers fascia (posterior), dorsal venous complex (anterior), puboprostatic ligaments, external urethral sphincter (apex), seminal vesicles, and bladder neck. Dissection planes for intrafascial, interfascial, and extrafascial nerve-sparing are indicated with color-coded lines. Surgical anatomy illustration style.</image>

<image>A diagram showing pelvic lymph node dissection templates during radical prostatectomy. An anterior view of the pelvis with the standard template (obturator fossa and external iliac nodes) highlighted in blue and the extended template (adding internal iliac, presacral, and common iliac nodes) highlighted in red. Anatomical landmarks labeled include external iliac artery and vein, obturator nerve, internal iliac artery, ureter, and common iliac bifurcation. The percentage of positive nodes detected by each template is annotated.</image>

<image>A comparison infographic of the three radical prostatectomy approaches (open retropubic, laparoscopic, robot-assisted) showing key metrics side by side: estimated blood loss, hospital stay, catheter duration, continence rates at 12 months, potency rates at 12 months, positive surgical margin rates, and learning curve (number of cases). Data presented as horizontal bar charts with values from major comparative series. Clean clinical comparison format.</image>

Clinical Pearls

Robot-assisted laparoscopic prostatectomy is the dominant surgical approach today, but oncologic outcomes are equivalent across approaches when performed by experienced surgeons, emphasizing that surgeon skill matters more than the robotic platform itself. Nerve-sparing should be carefully planned preoperatively using MRI, biopsy data, and cancer location, and oncologic outcomes should never be compromised for nerve preservation in high-risk disease. The apex is the most common site of positive surgical margins, so meticulous apical dissection with adequate urethral length is critical. PSA should be undetectable, below 0.1 ng/mL, by six weeks after surgery; any detectable PSA warrants close monitoring and potential further workup. Extended pelvic lymph node dissection provides essential staging information that influences decisions about adjuvant treatment and should not be omitted in intermediate and high-risk disease. While Retzius-sparing RALP may offer faster continence recovery, surgeons should first master the standard approach and be aware of the potentially higher positive margin rates associated with this technique. Early penile rehabilitation using phosphodiesterase type 5 inhibitors or vacuum devices may improve long-term potency recovery, although the evidence remains mixed.

References

• Walsh PC, Donker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol. 1982;128(3):492-497
• Ficarra V, et al. Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy. Eur Urol. 2012;62(3):418-430
• Yossepowitch O, et al. Positive surgical margins after radical prostatectomy: a systematic review and contemporary update. Eur Urol. 2014;65(2):303-313
• Dalela D, et al. A pragmatic randomized controlled trial comparing approaches to radical prostatectomy (PRAISE). J Urol. 2021;205(3):798-806
• NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer, Version 4.2024

Read this lecture as Markdown